3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
1320
Neoplasms
983
Carcinoma, Non-Small-Cell Lung
858
Prostatic Neoplasms
723
Colorectal Neoplasms
662
Lung Neoplasms
548
Leukemia, Myeloid, Acute
475
Neoplasm Metastasis
431
Pancreatic Neoplasms
418
Carcinoma, Hepatocellular
406
Multiple Myeloma
397
Ovarian Neoplasms
391
Stomach Neoplasms
378
Recurrence
365
Squamous Cell Carcinoma of Head and Neck
325
Melanoma
293
Brain Neoplasms
287
Uterine Cervical Neoplasms
283
Triple Negative Breast Neoplasms
271
Head and Neck Neoplasms
263
Glioblastoma
263
Precursor Cell Lymphoblastic Leukemia-Lymphoma
254
Endometrial Neoplasms
233
Lymphoma
227
Esophageal Neoplasms
222
Rectal Neoplasms
221
Sarcoma
211
Carcinoma, Renal Cell
203
Colonic Neoplasms
193
Lymphoma, Large B-Cell, Diffuse
191
Interventions
palbociclib
1
exemestane
1
elacestrant
1
Tamoxifen
1
Letrozole
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Interventional
×
ER+ Breast Cancer
×
Clear all
NCT06923527
2026-05-12
Circulating Tumor DNA
Yale University
Phase 2
Recruiting
50 enrolled
NCT04985266
2024-12-05
TRAK-ER
Royal Marsden NHS Foundation Trust
Phase 2
Recruiting
1,100 enrolled